ARTG 476391ZELTIQ system - Cryolipolysis skin contouring system
ARTG ID: 476391 · Abbvie Pty Ltd · Zeltiq Aesthetics Inc · Class IIb · Started January 22, 2025
Good Name: Abbvie Pty Ltd - ZELTIQ system - Cryolipolysis skin contouring system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 476391
- Start Date
- January 22, 2025
- Effective Date
- January 22, 2025
- Name
- Abbvie Pty Ltd
- Country
- United States of America
- Address
- 4410 Rosewood Drive , Pleasanton, CA, 94588
The CoolSculpting® System, also labeled as the ZELTIQ® System or the ZELTIQ® Breeze System (system), is a non-invasive cooling device that applies controlled cooling to a treatment site on the patient’s skin. The device is intended to be used for fat layer reduction through cold-assisted lipolysis (breakdown of fat) for aesthetic purpose.
Access comprehensive regulatory information for ZELTIQ system - Cryolipolysis skin contouring system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 476391 and sponsored by Abbvie Pty Ltd, manufactured by Zeltiq Aesthetics Inc in United States of America. The device registration started on January 22, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.